Competition Corner
Topics
Contributors
Sort by:
4 results
March 6, 2024
|4 min read
U.S. Antitrust Agencies Continue to Target Private Equity Involvement in Healthcare
In the latest step in the U.S. antitrust agencies’ heightened enforcement against private equity, the Federal Trade Commission held a Workshop on Private
Equity in Health Care yesterday with the U.S. Department of Justice and Department of Health and Human Services.
Equity in Health Care yesterday with the U.S. Department of Justice and Department of Health and Human Services.
November 1, 2023
|3 min read
New DOJ Safe-Harbor Policy Incentivizes M&A Due Diligence on Government Contractors
In analyzing a government contractor target for a proposed acquisition—such as a merger, asset sale, or stock purchase—due diligence may uncover a
seller’s noncompliance with certain Federal Acquisition Regulations or other applicable regulations.
seller’s noncompliance with certain Federal Acquisition Regulations or other applicable regulations.
September 28, 2023
|3 min read
FTC Seeks to Put Private Equity Roll-Up Strategies to Sleep
The Federal Trade Commission’s (FTC) continued scrutiny of private equity “roll-up” strategies resurfaced in a recent complaint filed in Texas federal court
alleging that the private equity firm Welsh, Carson, Anderson & Stowe (Welsh Carson) and its portfolio company U.S. Anesthesia Partners, Inc. (USAP) entered
into a “multi-year anticompetitive scheme to consolidate anesthesiology practices in Texas, drive up the price of anesthesia services provided to ...Read more
alleging that the private equity firm Welsh, Carson, Anderson & Stowe (Welsh Carson) and its portfolio company U.S. Anesthesia Partners, Inc. (USAP) entered
into a “multi-year anticompetitive scheme to consolidate anesthesiology practices in Texas, drive up the price of anesthesia services provided to ...Read more
October 21, 2022
|3 min read
Breaking the Interlocking Chain: DOJ’s Renewed Focus on Preventing Overlap Between Corporate Boards
The Antitrust Division of the United States Department of Justice (DOJ) announced that seven directors resigned from corporate board positions in response
to the DOJ’s concerns that their roles violated Section 8 of the Clayton Act’s prohibition on interlocking directorates. The resignations follow the DOJ’s
correspondence in late September to a number of public companies, in which it raised concerns based on statements in public filings that existin...Read more
to the DOJ’s concerns that their roles violated Section 8 of the Clayton Act’s prohibition on interlocking directorates. The resignations follow the DOJ’s
correspondence in late September to a number of public companies, in which it raised concerns based on statements in public filings that existin...Read more
About This Blog
Winston & Strawn’s Competition Corner features insights on recent legal developments in the antitrust arena as well as user-friendly guidance and practical tips for compliance.
Contributors
Partner
Partner
Partner
Partner
Partner
